Overview

Clinical Trial to Evaluate the Efficacy and Safety of 'DW1601' in Acute Bronchitis

Status:
Active, not recruiting
Trial end date:
2021-02-28
Target enrollment:
Participant gender:
Summary
A Multicenter, Randomized, Double-Blind, Parallel, Active-controlled, Superiority, Phase III Clinical Trial to Evaluate the Efficacy and Safety of DW1601 Compared to DW16011 and DW16012 for Acute Bronchitis
Phase:
Phase 3
Details
Lead Sponsor:
Daewon Pharmaceutical Co., Ltd.